SEC Filings for Dr. Reddy's Laboratories Ltd (RDY)

$ 51.89   -0.37 (-0.71%) Volume: 225.82k 7:00 PM EDT Jul 9, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934812/05/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934812/05/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341010/05/2007
20-FRegistration statement / Annual report / Transition report18509/26/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19345309/19/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341309/18/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/18/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19345109/17/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934107/03/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934907/13/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341706/26/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341305/15/2007
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans2403/05/2007
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/14/2007
SC 13GStatement of acquisition of beneficial ownership by individuals102/14/2007
282930313233343536373839404142